kidney cancer

Keytruda-Inlyta Combo Approved by FDA for Untreated Advanced Kidney Cancer immuno-oncologynews.com

immuno-oncologynews.com/2019/04/30/keytruda-inlyta-combo-approved-fda-untreated-advanced-kidney-cancer/Ines Martins, PhDApril 30, 2019 The U.S. Food and Drug Administration (FDA) has approved a combination of Keytruda (pembrolizumab) plusInlyta (axitinib) for the initial treatment of patients

Keytruda-Inlyta Combo Approved by FDA for Untreated Advanced Kidney Cancer immuno-oncologynews.com2019-05-07T20:56:08-04:00

U.S. Senate Support for Kidney Cancer

This week U.S. Senator Kirsten Gillibrand (D-NY) joined with several other colleagues requesting support for an increase in kidney cancer research. The

U.S. Senate Support for Kidney Cancer2019-04-16T09:14:01-04:00